Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker

BACKGROUND: This study was initiated to investigate the prognostic significance of circulating tumor cell (CTC) enumeration and the predictive value of CTC HER2 expression for efficient anti-HER2 therapy in HER2-positive metastatic breast cancer (MBC) patients. METHODS: Sixty HER2-positive MBC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Liu, Qian, Wang, Tao, Bian, Li, Zhang, Shaohua, Hu, Haixu, Li, Sha, Hu, Zhiyuan, Wu, Shikai, Liu, Bing, Jiang, Zefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643882/
https://www.ncbi.nlm.nih.gov/pubmed/23617715
http://dx.doi.org/10.1186/1471-2407-13-202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643882/
https://www.ncbi.nlm.nih.gov/pubmed/23617715
http://dx.doi.org/10.1186/1471-2407-13-202

Ejemplares similares